Biases in patent examination and firms’ responses
Evidence from the pharmaceutical industry
Bibliographic Data
| ID | 12918050 |
|---|---|
| Authors | Fei Yu (0000-0002-2824-9866, Tsinghua University), Yanrui Wu (0000-0002-8966-1459, The University of Western Australia, corresponding author), J Chen (0000-0002-0156-9237, Tsinghua University) |
| Year | 2016 |
| Volume | 9 |
| Issue | 2 |
| Pages | 101-115 |
| Publication date | 2016-03-29 |
| Peer Reviewed | Yes |
| Open Access | No |
| Type | ARTICLE |
| Venue | China Economic Journal (JOURNAL) |
| Journal identifiers | ISSN: 1753-8963 • E-ISSN: 1753-8971 |
| Publisher | Routledge (PUBLISHER • GB) |
| DOI | 10.1080/17538963.2016.1160535 |
| OpenAlex | W2320450423 |
| Language | EN |
| Citations received | 1 |
| References cited | 27 |
Empirical analysis of matched patent application data in the world’s major patent offices has shown considerable variation in patent granting probability and examination duration across different countries. This phenomenon is attributed to institutional misclassifications or patent examiners’ mistakes by some authors. Others argued that cross-country heterogeneity could also be caused by deliberate manipulation of patent examination procedures with the goal to foster native inventors through suppressing foreign patent applicants. To explore whether manipulation exists, this study presents a case study of pharmaceutical patents granted by the US patent office and approved by the US FDA. Especially it focuses on the filing behavior of pharmaceutical companies in Korea, Japan and China. The regression results show that the granting ratio of the previous applications of a foreign company is correlated with the company’s probability of lodging a new patent application, which provides a supplementary evidence of the existence of the manipulated patent examination procedures
Actuarial science · Business · China · Empirical examination · Industrial organization · Patent application · Patent office · Pharmaceutical industry · Phenomenon · Political science · Innovation Policy and RD · Intellectual Property and Patents · Law · Medicine · Pharmaceutical Economics and Policy · Marketing
Fitting Heterogeneous Choice Models with Oglm
Language and foreign trade
Market Size in Innovation
Generalized Ordered Logit/Partial Proportional Odds Models for Ordinal Dependent Variables
Pharmaceutical Price Controls and Entry Strategies
Misclassification between Patent Offices
Examiner Characteristics and Patent Office Outcomes
Do National Patent Laws Stimulate Domestic Innovation in a Global Patenting Environment? A Cross-Country Analysis of Pharmaceutical Patent Protection, 1978–2002
The patterns of patents in China
| Unique citing works | 1 |
|---|---|
| Citations per year | 0,33 |
| Citation span | 2023 - 2023 (1) |
| Citation velocity | historical |
| Highly cited | No |
| Citation types | Neutral: 1 |